Evidence brief
Teriparatide
Written and source-checked by Anthony Treviso, founder of The Peptide Field.
Direct answer
FDA-approved products exist for specific osteoporosis populations.
An established osteoporosis medicine that can reduce fracture risk in defined groups. Its evidence does not apply to every fracture-healing claim.
- How strong is the evidence?
- Established
An official agency review or strong, repeated studies in people support one clear use. That evidence applies only to the product, people, and use we reviewed. It does not mean the product is safe or effective for everyone. - What evidence exists?
- Approved human outcomes
Approved products have evidence from studies in people that measured health results for specific uses. This does not show that every product, person, or use has the same result. - Sports rules
- Not assessed
No current sports-rule review is available.
Reviewed July 23, 2026. Sources and update notes are below.
No sales or dosing advice. This guide explains research. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.
Also known as Forteo · PTH 1-34 · recombinant human parathyroid hormone 1-34
Part of Bone peptide medicines
Words used here
- outcome
- what the study measured
- randomized
- assigned to study groups by chance
- peptide
- a short chain of amino acids
- analog
- a changed version made to act like another substance
- amino acid
- a small building block that makes peptides and proteins
More detailProduct and study details
01 · Evidence profile
Four questions about the evidence
Randomized evidence supports vertebral and nonvertebral fracture-risk reduction in defined osteoporosis populations.
Bone-turnover, exposure, and product-specific pharmacology are well characterized.
Labels describe hypercalcemia, orthostatic hypotension, osteosarcoma risk factors, and other precautions.
High for authentic approved products used within the label.
02 · Identity
What it is
Teriparatide is a 34-amino-acid piece of human parathyroid hormone. It is used as a prescription medicine to help build bone in osteoporosis.
Scientific group: Parathyroid hormone analogue. This group name describes the type of molecule or body signal. It does not prove a benefit, safety, or approval.
03 · Exact product
The molecule is not the finished product.
Formulation: The finished product's ingredients and physical form. Route: How the product enters the body. Indication: The approved or studied use and group of people for a product.
Forteo
2024 label- Formulation
- Prefilled delivery device
- Route
- Subcutaneous
- Indication scope
- Osteoporosis uses in the high-fracture-risk populations defined in the product label.
- Forteo
- approved teriparatide products
- Osteoporosis treatment in labeled high-fracture-risk populations
04 · Research results
What the research shows
Controlled trials and approved labeling support fewer spine and non-spine fractures in defined osteoporosis groups at high fracture risk.
This evidence does not prove faster healing for every new fracture, universal benefit in athletes, or safety outside monitored prescription use.
Exact product
The evidence applies to specific approved products and groups of people. Teriparatide evidence concerns approved drug products and labeled osteoporosis populations, not every product called PTH 1-34 or every type of fracture.
05 · Claim check
Claims I checked
3 claims checked for this brief.
“Teriparatide reduces fracture risk in defined osteoporosis populations.”
The pivotal evidence and label support vertebral and nonvertebral fracture-risk reduction in studied high-risk populations.
- Evidence used
- Randomized human outcomes. This answer uses a study that assigned people to groups by chance and measured a health outcome.
- Limits of this answer
- Labeled osteoporosis populations at high fracture risk. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
“Teriparatide is proven to heal every fracture faster.”
Fracture prevention and acute fracture healing are different endpoints, and trial results vary by fracture setting.
- Evidence used
- Randomized human outcomes. This answer uses a study that assigned people to groups by chance and measured a health outcome.
- Limits of this answer
- Acute fracture-healing outcomes across all fracture types. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
“Because teriparatide is a peptide, it has no serious risks.”
The current label includes clinically important warnings, precautions, and population restrictions.
- Evidence used
- Regulatory or product record. This answer uses an official regulator record or a specific product label.
- Limits of this answer
- Approved teriparatide product use. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
06 · Questions
Questions people ask about Teriparatide
FDA-approved products exist for specific osteoporosis populations. Approved products identified: Forteo, approved teriparatide products.
Not assessed. This editorial review did not determine sport eligibility. Athletes must check the current prohibited list, Global DRO, and their governing body. This status is not personal clearance to compete.
Controlled trials and approved labeling support fewer spine and non-spine fractures in defined osteoporosis groups at high fracture risk.
This evidence does not prove faster healing for every new fracture, universal benefit in athletes, or safety outside monitored prescription use.
07 · Safety
Safety limits for this record
The label has important limits on duration, risk factors, calcium, and monitoring. No dose, injection, or off-label fracture-healing instructions are provided.
This editorial review did not determine sport eligibility. Athletes must check the current prohibited list, Global DRO, and their governing body.
No current sports-rule review is available.
Reviewed .Check current rules for tested sport ↗08 · Sources
Read the sources
09 · Review history
Review history
Initial brief based on the current Forteo label and fracture-prevention trial record.
Written and source-checked by Anthony Treviso, founder of The Peptide Field.
Not independently medically reviewed. This page is not a dosing, sourcing, or treatment guide.